Spiker D G, Weiss J C, Dealy R S, Griffin S J, Hanin I, Neil J F, Perel J M, Rossi A J, Soloff P H
Am J Psychiatry. 1985 Apr;142(4):430-6. doi: 10.1176/ajp.142.4.430.
The authors investigated the pharmacological treatment of delusional depression by assigning patients on a random double-blind basis to amitriptyline alone, perphenazine alone, or a combination of the two. Fourteen (78%) of the 18 patients assigned to amitriptyline plus perphenazine were responders, compared with seven (41%) of 17 patients treated with amitriptyline alone and three (19%) of the 16 patients treated with perphenazine alone. The combination of amitriptyline and perphenazine was clearly superior (p less than .01).
作者通过将患者随机双盲分配至单独使用阿米替林、单独使用奋乃静或两者联合使用,研究了妄想性抑郁症的药物治疗。分配至阿米替林加奋乃静组的18例患者中有14例(78%)有反应,而单独使用阿米替林治疗的17例患者中有7例(41%)有反应,单独使用奋乃静治疗的16例患者中有3例(19%)有反应。阿米替林和奋乃静联合使用明显更有效(p小于0.01)。